C J Hackbarth
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus
- Tuberculosis Research and Epidemiology
Papers in
-
- Antimicrobial Resistance in Staphylococcus 25
- Pharmacology 20
- Antibiotics Pharmacokinetics and Efficacy 16
- Co-authors
- Henry F. Chambers (20 shared papers)Merle A. Sande (18 shared papers)Joaquim Trias (10 shared papers)Martin G. Täuber (4 shared papers)Richard White (9 shared papers)Thomas A. Drake (5 shared papers)Zhengyu Yuan (5 shared papers)Martin Rusňák (4 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (24 papers)The Journal of Infectious Diseases (6 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Antimicrobial Chemotherapy (2 papers)Infection and Immunity (1 paper)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
C J Hackbarth
48 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 108
- Molecular Medicine 846
- Infectious Diseases 1.4k
- Clinical Biochemistry 435
- Microbiology 375
- Pharmacology 807
Countries citing papers authored by C J Hackbarth
This map shows the geographic impact of C J Hackbarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C J Hackbarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C J Hackbarth more than expected).
Fields of papers citing papers by C J Hackbarth
This network shows the impact of papers produced by C J Hackbarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C J Hackbarth. The network helps show where C J Hackbarth may publish in the future.
Co-authors
The 25 scholars most cited alongside C J Hackbarth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 259 | |
| 2 | 2001 | 215 | |
| 3 | 1995 | 174 | |
| 4 | 1988 | 159 | |
| 5 | 1993 | 159 | |
| 6 | 1987 | 149 | |
| 7 | 1989 | 120 | |
| 8 | 1989 | 118 | |
| 9 | 2000 | 114 | |
| 10 | 1996 | 106 | |
| 11 | 1984 | 96 | |
| 12 | 1986 | 95 | |
| 13 | 1987 | 82 | |
| 14 | 1986 | 80 | |
| 15 | 1995 | 79 | |
| 16 | 1998 | 66 | |
| 17 | 1994 | 63 | |
| 18 | 2001 | 62 | |
| 19 | 2003 | 61 | |
| 20 | 1985 | 60 |
About C J Hackbarth
C J Hackbarth is a scholar working on Infectious Diseases, Pharmacology, Molecular Biology, Epidemiology and Molecular Medicine, having authored 48 papers that have together received 3.2k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (25 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers), Antibiotic Resistance in Bacteria (13 papers), Infective Endocarditis Diagnosis and Management (7 papers), Bacterial Infections and Vaccines (6 papers), RNA and protein synthesis mechanisms (5 papers), Peptidase Inhibition and Analysis (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). The work is most often cited by research in Molecular Medicine (846 citations), Infectious Diseases (1.4k citations), Clinical Biochemistry (435 citations), Microbiology (375 citations) and Pharmacology (807 citations). C J Hackbarth has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Henry F. Chambers, Merle A. Sande, Joaquim Trias, Martin G. Täuber, Richard White, Thomas A. Drake, Zhengyu Yuan, Martin Rusňák, Wen Wang and Peter S. Margolis. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, Bioorganic & Medicinal Chemistry Letters, Journal of Antimicrobial Chemotherapy and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.